Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 4/20 | 0.55 |
| ▸ | CA1 | P00915 | 8/20 | 0.43 |
| ▸ | CA2 | P00918 | 8/20 | 0.43 |
| ▸ | CA9 | Q16790 | 8/20 | 0.43 |
| ▸ | CDK2 | P24941 | 3/20 | 0.42 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.42 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.42 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.42 |
| ▸ | CDK9 | P50750 | 2/20 | 0.40 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.40 |
| ▸ | CDK1 | P06493 | 2/20 | 0.40 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.40 |
| ▸ | CDK7 | P50613 | 2/20 | 0.40 |
| ▸ | CCNH | P51946 | 2/20 | 0.40 |
| ▸ | MNAT1 | P51948 | 2/20 | 0.40 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12952999 | 0.90 | GSK3B (0.68) | GSK3BCA1CA2CA9CDK2 | |
| SCHEMBL13116953 | 0.82 | GSK3B (0.67) | GSK3BCDK2CHEK1CCNA2CCNA1 | |
| SCHEMBL13146410 | 0.80 | GSK3B (0.79) | GSK3BCDK2CHEK1CCNA2CCNA1 | |
| SCHEMBL13304833 | 0.80 | CA2 (0.52) | GSK3BCA1CA2CA9 | |
| SCHEMBL13305324 | 0.80 | GSK3B (0.51) | GSK3BCDK2CHEK1CCNA2CCNA1 | |
| SCHEMBL13304620 | 0.79 | GSK3B (0.50) | GSK3BCDK2CHEK1CCNA2CCNA1 | |
| SCHEMBL13146206 | 0.79 | GSK3B (0.51) | GSK3BCDK2CHEK1CCNA2CCNA1 | |
| SCHEMBL13305175 | 0.76 | GSK3B (0.48) | GSK3BCDK2CHEK1CCNA2CCNA1 | |
| SCHEMBL14050973 | 0.75 | GSK3B (0.62) | GSK3BCA1CA2CDK2CCNA2 | |
| SCHEMBL12953472 | 0.75 | GSK3B (0.70) | GSK3BCDK2CHEK1CCNA2CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1537116-B1 | PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES | SCHERING CORP (US) | 2010-06-02 | — | — | EP | disclosed |